Junhang Luo
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 5%
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation
Papers in
-
- Cancer-related molecular mechanisms research 16
- Urology 9
- Journals
- Oncogene (4 papers)Cancer Medicine (3 papers)Cancer Science (3 papers)Molecular Cancer (3 papers)BMC Urology (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Junhang Luo
112 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 132
- Cancer Research 1.2k
- Molecular Biology 1.9k
- Pulmonary and Respiratory Medicine 752
- Oncology 503
- Urology 107
Countries citing papers authored by Junhang Luo
This map shows the geographic impact of Junhang Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junhang Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junhang Luo more than expected).
Fields of papers citing papers by Junhang Luo
This network shows the impact of papers produced by Junhang Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junhang Luo. The network helps show where Junhang Luo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Junhang Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 5 | |
| 3 | 2023 | 6 | |
| 4 | 2023 | 32 | |
| 5 | 2023 | 13 | |
| 6 | 2023 | 14 | |
| 7 | 2022 | 23 | |
| 8 | 2022 | 47 | |
| 9 | 2021 | 85 | |
| 10 | 2021 | 137 | |
| 11 | 2021 | 33 | |
| 12 | 2021 | 28 | |
| 13 | 2021 | 10 | |
| 14 | 2021 | 1 | |
| 15 | 2020 | 4 | |
| 16 | 2019 | 5 | |
| 17 | 2018 | 55 | |
| 18 | 2018 | 281 | |
| 19 | 2014 | 21 | |
| 20 | 2013 | 10 |
About Junhang Luo
Junhang Luo is a scholar working on Cancer Research, Urology, Pulmonary and Respiratory Medicine, Oncology and Surgery, having authored 118 papers that have together received 3.5k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (27 papers), Ferroptosis and cancer prognosis (20 papers), Renal cell carcinoma treatment (17 papers), Cancer-related molecular mechanisms research (16 papers), Circular RNAs in diseases (13 papers), RNA modifications and cancer (12 papers), Epigenetics and DNA Methylation (12 papers) and Cancer Immunotherapy and Biomarkers (11 papers). The work is most often cited by research in Cancer Research (1.2k citations), Molecular Biology (1.9k citations), Pulmonary and Respiratory Medicine (752 citations), Oncology (503 citations) and Urology (107 citations). Junhang Luo has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Dan Xie, Jinhuan Wei, Jiaxing Zhang, Yong Fang, Haohua Yao, Junjie Cen, Lei Tan, Jun Lü, Fangjian Zhou and Bing Liao. Their work appears in journals such as Oncogene, Cancer Medicine, Cancer Science, Molecular Cancer and BMC Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.